- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer
Total 16927 results
-
Hinova Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerChina
-
Yale UniversityDendreonRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Erasmus Medical CenterRecruitingMetastatic Castration-resistant Prostate CancerNetherlands
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Robert Flavell, MD, PhDUnited States Department of Defense; Fortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University of California, San DiegoRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
University of UtahAstellas Pharma IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...BayerRecruitingMetastatic Castration-resistant Prostate CancerItaly
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerChina
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
University of UtahBayerCompletedProstate Cancer Metastatic to BoneUnited States
-
Immunic AGTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Eli Lilly and CompanyCompletedMetastatic Castration-Resistant Prostate CancerFrance, United States, Spain
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
Veru Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Novo Nordisk A/STerminated
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...CompletedMetastatic Castration-resistant Prostate CancerChina
-
University of California, San FranciscoNational Cancer Institute (NCI); Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Castration Levels of Testosterone | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
DendreonCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateAustria, France, Netherlands, United Kingdom
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
Roswell Park Cancer InstituteUniversity of PittsburghCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateUnited States
-
University of SaskatchewanSanofiTerminatedPlatinum Sensitive Relapsed Ovarian CancerCanada
-
Rhizen Pharmaceuticals SACompletedSolid Tumor | Metastatic Breast Cancer | Locally Advanced Breast Cancer | Extensive-stage Small-cell Lung Cancer | Platinum-Sensitive Fallopian Tube Carcinoma | Platinum-sensitive Ovarian Cancer | Platinum-Sensitive Peritoneal CancerCzechia, Poland
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaboratorsCompletedProstate Cancer | Metastatic CancerUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedProstate Cancer | Metastatic CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Jonsson Comprehensive Cancer CenterCompletedBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | PSA Level Greater Than FiftyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Recurrent Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8
-
Erasmus Medical CenterRecruitingProstate Cancer MetastaticNetherlands
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
DendreonNot yet recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstitutePfizer; Prostate Cancer FoundationRecruitingProstate Cancer | Prostate Cancer Metastatic | Androgen Deprivation TherapyUnited States
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Czechia, France, Hungary, Italy, Poland, Spain, Taiwan, United Kingdom, Korea, Republic of, Singapore, Hong Kong, Australia, Finland, Germany, Israel, Lithuania, Russian Federation, Turkey, Austria